Search

Hear about the benefits of receiving surgery, treatment and rehabilitation close to home.

… Hear about the benefits of receiving surgery, treatment and rehabilitation close to home. Getting diagnosed with cancer is stressful. It’s scary. It’s life-changing. And then, too, on top of that, now I need to try to coordinate how I am going to be getting my treatment. Being able to get the best cancer

Realiza un recorrido virtual por nuestro centro MSK Bergen para pacientes ambulatorios.Este ofrece a los residentes de Nueva Jersey y el sur de Nueva York la posibilidad de recibir tratamiento y rehabilitación cerca de su hogar.

… Realice un recorrido virtual por nuestra ubicación ambulatoria de MSK Bergen, que ofrece a los residentes del norte de Nueva Jersey y el sur de Nueva York el beneficio de recibir tratamiento y rehabilitación cerca de casa. Recibir un diagnóstico de cáncer es estresante. Te da miedo. Te cambia la vida

… Job Title Senior Associate Scientist at Generation Bio Links https://www.linkedin.com/in/declan-gwynne/ (CV) I am a mechanical engineer by education, having received my bachelor’s in mechanical engineering from University of Massachusetts Amherst in 2018. After graduating, I worked as a research technician

This form will help you keep track of when you take your medications, how much you urinate (pee), and your urine pH.

Este formulario le ayudará a realizar un seguimiento de cuándo toma sus medicamentos, cuánto orina y el nivel de pH de su orina.

Эта форма поможет вам отслеживать время приема лекарств, количество мочеиспусканий и уровень рН мочи.

本表可帮助您记录服药时间、尿量和尿液 pH 值。

MSK cancer biologist Scott Lowe, PhD, delivers his MSK Science Spotlight lecture on April 13, 2020.

… MSK cancer biologist Scott Lowe, PhD, delivers his MSK Science Spotlight lecture on April 13, 2020.

… As President and Chief Executive Officer, Dr. Marks led Memorial Sloan Kettering Cancer Center for 19 years, beginning in 1980. After stepping down from that role in 1999, he remained a vital part of Memorial Sloan Kettering for many years as President Emeritus and Member of the Sloan Kettering Institute

… Full Title A Randomized, Phase II Study of Enzalutamide, Enzalutamide With Mifepristone, and Treatment of Physician’s Choice in Patients with AR+ Metastatic Triple-Negative or ER-Low Breast Cancer Purpose In this study, researchers want to see if enzalutamide, alone or with mifepristone, works well against